For generations, waking up with a pounding headache, grappling with persistent afternoon anxiety, or fighting an overwhelming urge to close your eyes at your desk has been written off as an unfortunate side effect of modern life. For women, these vague yet debilitating symptoms are frequently attributed to menstruation, the transition into menopause, or the sheer exhaustion of motherhood. However, medical experts warn that these persistent complaints may actually stem from a serious, highly prevalent health condition that has historically been dismissed as a strictly "male disease": obstructive sleep apnea, or OSA.
If the phrase "sleep apnea" immediately conjures the mental image of an older man dozing loudly on a couch and snoring with the volume of a lawn mower, you are certainly not alone. For decades, medical research viewed the disorder through a profoundly male-centric lens. It was not until the 1990s that researchers first began recognizing that OSA—a disorder characterized by repeated interruptions in breathing during sleep—often presents in a fundamentally different manner in women than it does in men. Most notably, many women suffering from the condition do not snore at all, entirely missing the hallmark sign that traditionally prompts medical professionals to investigate further.
While researchers are still working to fully map out the underlying biology, current studies suggest that a complex interplay of hormonal fluctuations across a woman’s lifespan, distinct anatomical differences in the upper airway, and even social stigmas surrounding how women are expected to sleep all contribute to this diagnostic blind spot.
"The disease itself was defined in men," explains Jennifer Martin, PhD, a behavioral sleep medicine specialist and professor at Florida International University’s Herbert Wertheim College of Medicine in Miami. "The way men and women breathe when they’re asleep is not the same, and our definition of the disease doesn’t account for that."
Although obstructive sleep apnea appears to be statistically less common and typically milder in women during their premenopausal years, emerging evidence indicates that the long-term consequences of the untreated disease can be just as severe—if not worse—for women compared to men. This stark reality makes understanding the atypical signs and actively seeking appropriate medical intervention critical.
How and Why Sleep Apnea Differs in Women
Sleep apnea falls under the broader category of sleep-disordered breathing. The most frequent manifestation is obstructive sleep apnea, which occurs when the upper airway repeatedly collapses during slumber, restricting the flow of air to the lungs, according to Anita Valanju Shelgikar, MD, a sleep medicine physician with University of Michigan Health and president of the American Academy of Sleep Medicine.
The textbook presentation of OSA—established through clinical studies that overwhelmingly relied on male participants—includes loud snoring and dramatic gasps for air as an individual struggles to resume breathing overnight. However, Dr. Shelgikar notes that this clinical picture rarely aligns with the experiences of female patients. Instead, women dealing with OSA are significantly more likely to experience nightmares, frequent nocturnal awakenings, difficulties returning to sleep, and persistent insomnia. These sleep disruptions subsequently manifest during waking hours as severe fatigue, morning headaches, and volatile mood swings. Furthermore, women tend to experience a higher frequency of hypopneas, which are characterized by shallow breaths accompanied by diminished oxygen flow, whereas men are more prone to apneas, defined as complete pauses in breathing.
Some experts hypothesize that snoring is less frequently reported among women due to social embarrassment, given that societal expectations often cast women as peaceful, quiet sleepers. Yet, biological factors offer a much more robust explanation for these sex-based differences. Compared to men, women generally possess smaller, structurally more stable airways that are less prone to collapsing and vibrating during sleep. Additionally, women tend to carry less adipose tissue around their necks. Before menopause, women also benefit from the protective physiological effects of estrogen and progesterone, hormones that interact directly with the respiratory system to support stable breathing patterns.
These physiological factors help explain why statistics show more men than women in the United States currently diagnosed with the condition, accounting for approximately 59% and 41% of obstructive sleep apnea patients, respectively. However, once women transition through menopause and experience a natural decline in estrogen and progesterone levels, the prevalence of OSA and the severity of its symptoms increase dramatically, Dr. Martin notes. Research indicates that anywhere from 47% to 67% of postmenopausal women suffer from obstructive sleep apnea, a prevalence rate that parallels or even exceeds that of men in the same age demographic. Despite these numbers, the rate at which women receive an accurate clinical diagnosis remains disproportionately low.
Regardless of age, women frequently contend with a higher burden of sleep apnea-related symptoms compared to men, even when their objective disease classification is milder. Dr. Martin attributes this discrepancy to the fact that women experience more subtle breathing disturbances throughout the night that cumulatively degrade the overall restorative quality of their rest.
Why Misdiagnoses Are Common in Women with Sleep Apnea
Because women frequently fail to display the "classic" symptoms associated with obstructive sleep apnea, they are frequently misdiagnosed or have their health concerns dismissed entirely by medical providers.
"When [men] walk into a physician’s office and say they’re sleepy and they snore, they get a diagnostic test right away," Dr. Martin says. "When a woman walks in and says, ‘I don’t sleep well, and I’m very fatigued during the day,’ they don’t often get referred" for proper screening. In fact, existing literature suggests that men are roughly nine times more likely to be referred for diagnostic sleep testing than women presenting with similar fatigue levels.
Women with OSA frequently find their symptoms attributed to entirely separate conditions, such as clinical depression, generalized anxiety disorder, primary insomnia, menopausal transitions, or even pharmaceutical side effects, explains Dr. Shelgikar, who is also a neurology professor at the University of Michigan Medical School. Compounding the issue, women can experience these comorbid conditions simultaneously, which not only obscures the underlying sleep apnea but can actively worsen it.
Consider the complex overlap of insomnia and OSA. Suffering from both disorders concurrently is statistically more common among women than men, according to Dr. Martin. In some instances, these patients may be prescribed sleep aids—such as diphenhydramine or benzodiazepines—that induce muscle relaxation in the throat, inadvertently exacerbating their sleep apnea and leaving them in a state of even greater oxygen deprivation.
This diagnostic challenge is further compounded by the fact that established diagnostic criteria for OSA are heavily rooted in male presentation patterns.
"When we diagnose sleep apnea, we require one of two things to happen: A breathing interruption has to be associated either with a drop in oxygen levels or a brief awakening from sleep," Dr. Martin explains. "Women don’t have those very deep drops in oxygen levels that men do. So that means that the way we define the disease itself kind of biases us towards diagnosing it more in men than women."
This bias is codified even within major healthcare systems. Medicare, the federal health insurance program relied upon by the vast majority of Americans aged 65 and older, typically recognizes a sleep apnea diagnosis only when documented breathing disruptions are accompanied by steep drops in blood oxygen saturation levels. Standard mid-slumber micro-awakenings alone often fail to satisfy these strict administrative thresholds. As a result, Dr. Martin notes, the very criteria mandated by federal insurers remain fundamentally male-centric.
Furthermore, home sleep apnea tests, which have surged in popularity as a cost-effective alternative to comprehensive in-lab polysomnography, are notably more likely to miss cases in female patients. Because women tend to exhibit fewer and less pronounced breathing events, portable home monitors may fail to capture the full scope of the disorder. The accuracy drops even further for women struggling with coexisting insomnia. These individuals may fail to log a sufficient quantity of sleep during the monitoring period to yield a reliable assessment, resulting in an underestimation of the severity of their sleep apnea.
Experts emphasize that obstructive sleep apnea is likely far more prevalent among women than current health data indicates. This diagnostic oversight leaves countless women without the medical care they require, creating a dangerous delay that can eventually snowball into a cascade of preventable health complications.
Why You Should Treat Your Sleep Apnea
When left unmanaged, obstructive sleep apnea exerts profound downstream effects on systemic health, with the cardiovascular system bearing a particularly heavy toll, notes Atul Malhotra, MD, research chief of pulmonary, critical care, and sleep medicine at UC San Diego Health.
Each time a patient stops breathing during the night, the body interprets the sudden lack of oxygen as an acute crisis, releasing stress hormones like adrenaline to trigger a brief micro-awakening that forces a gasp for air. This cycle occurs rapidly, often lasting only a few seconds, leaving the individual entirely unaware of the disruption by morning.
Over extended periods, this chronic physiological stress strains the cardiovascular system, elevating the long-term risk of hypertension, myocardial infarction, stroke, cardiac arrhythmias, and heart failure. Although clinical evidence remains nuanced, some studies indicate that women suffering from severe sleep apnea may experience cardiovascular complications at rates comparable to or exceeding those of men. Research also demonstrates that women frequently present with a higher burden of concurrent health conditions at the time of an OSA diagnosis, including thyroid disorders, asthma, and depression. While this presents a classic "chicken or the egg" medical dilemma, treating the underlying sleep apnea consistently yields positive health outcomes.
Because obstructive sleep apnea severely degrades sleep quality, it is closely linked to cognitive impairments, memory lapses, and diminished daytime alertness. These deficits can significantly increase the risk of automobile collisions and workplace accidents, particularly in safety-sensitive industries such as transportation and construction, Dr. Shelgikar points out.
Less frequently discussed is the heavy toll untreated sleep apnea takes on emotional well-being, personal care, and interpersonal relationships.
"We don’t do a good job thinking about sleep apnea as a potential cause of mental health symptoms," Dr. Martin says. Clinical studies increasingly show that effectively managing and treating OSA can play a meaningful role in alleviating symptoms for individuals struggling with anxiety and depression.
Even amidst these systemic diagnostic hurdles, medical experts point to an encouraging reality: clinical evidence demonstrates that women respond exceptionally well to standard therapies, such as continuous positive airway pressure (CPAP) treatment, often benefiting just as much as men—if not more. Recognizing the distinct ways the condition manifests remains the vital first step toward reclaiming restorative rest and long-term health.
